Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study.
Yoon M, Lee HK, Park EY, Kim JH, Lee JH, Kim YS, Kim HJ, Kim H, Yoo CW, Lee S, Hong EK, Kim TH, Kim TS, Seo SS, Kang S, Chang SJ, Shin HJ, Uong TNT, Lee S, Kim JY. Yoon M, et al. Among authors: hong ek. Int J Cancer. 2022 Dec 15;151(12):2182-2194. doi: 10.1002/ijc.34190. Epub 2022 Jul 11. Int J Cancer. 2022. PMID: 35751421 Free article. Clinical Trial.
Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer.
Yoo T, Lee WJ, Woo SM, Kim TH, Han SS, Park SJ, Moon SH, Shin KH, Kim SS, Hong EK, Kim DY, Park JW. Yoo T, et al. Among authors: hong ek. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e623-30. doi: 10.1016/j.ijrobp.2011.02.063. Epub 2011 May 19. Int J Radiat Oncol Biol Phys. 2011. PMID: 21600705
Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study.
Woo SM, Kim MK, Joo J, Yoon KA, Park B, Park SJ, Han SS, Lee JH, Hong EK, Kim YH, Moon H, Kong SY, Kim TH, Lee WJ. Woo SM, et al. Among authors: hong ek. Cancer Res Treat. 2017 Oct;49(4):1022-1032. doi: 10.4143/crt.2016.495. Epub 2017 Jan 19. Cancer Res Treat. 2017. PMID: 28111423 Free PMC article.
233 results